Study shows drop in life expectancy in the Gaza Strip
A collaborative team of international researchers estimate that between Oct. 2023 and Sep. 2024 compared to pre-war levels, life expectancy in the Gaza Strip almost halved.
Displaced Palestinians outside their tents near the seaside in Deir al-Balah in the central Gaza Strip in January 2025, following a ceasefire between Israel and Hamas.
(Image: Majdi Fathi/NurPhoto via AP)
Life expectancy in the Gaza Strip has been nearly cut in half (-46.3%) since the current war began in October 2023, according to new estimates published in The Lancet. The study led by Michel Guillot, professor of sociology in the School of Arts & Sciences, and a team of international collaborators found that life expectancy dropped from a pre-war average of 75.5 years to 40.5 years for the period of time between October 2023 and September 2024. The decrease in life expectancy was higher for men (-51.6%; 73.6 years pre-war to 35.6 years) than for women (-38.6%; 77.4 years pre-war to 47.5 years).
The authors calculated three life expectancy scenarios:
The central scenario—based on the official count of fatalities from the Gaza Ministry of Health, excluding the estimated count of individuals reported missing or under the rubble, estimates life expectancy between Oct. 2023 and Sep. 2024 to be 40.5 years
The low scenario—based on deaths for which complete identifying information was available—estimates life expectancy between Oct. 2023 and Sep. 2024 to be 44.4 years
The high scenario—based on the official count of fatalities from the Gaza Ministry of Health, including the lower bound of the estimated count of individuals reported missing or under the rubble—estimates life expectancy between Oct. 2023 and Sep. 2024 to be 36.1 years
The authors caution that the central scenario estimate of 40.5 years life expectancy includes deaths for people whose identification information was not complete and whose existence could not be cross-checked against the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) register. As the estimate doesn’t include individuals reported missing or under the rubble it may still be an underestimation. Additionally, the authors highlight that none of the scenarios include the indirect effects of the war—such as lack of access to health care and malnutrition—on mortality.
Michel Guillot is a professor in the Department of Sociology and a research associate in the Population Study Center in the School of Arts & Sciences at the University of Pennsylvania.
Other authors on the study include Penn Ph.D. candidate José H C Monteiro Da Silva; Mohammed Draidi of the Palestinian Central Bureau of Statistics, Ramallah, Palestine; Valeria Cetorelli of the UN Relief and Works Agency for Palestine Refugees in the Near East, Amman, Jordan; and Ismail Lubbad UN Economic and Social Commission for Western Asia, Beirut, Lebanon.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
